Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +130.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed +143.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Net income changed -27.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed -20.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -31.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed -126 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed +15.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +3.4% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Inventory / revenue changed +1545 basis points from the comparable as-filed period.
Operating income changed -9.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +284.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +401 basis points from the comparable as-filed period.
Operating cash-flow margin changed +431 basis points from the comparable as-filed period.
Working capital changed -18.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed -31 basis points from the comparable as-filed period.
Receivables / revenue changed -744 basis points from the comparable as-filed period.
Working capital / assets changed -210 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed -7.4% from the comparable as-filed period.
Total assets changed -13.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +7.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current assets changed -10.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -17.5% from the comparable as-filed period.
R&D / revenue changed +103 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed -8.2% from the comparable as-filed period.
Capex / revenue changed +30 basis points from the comparable as-filed period.
SBC / revenue changed -21 basis points from the comparable as-filed period.
Current liabilities changed -3.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -7.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.